You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gleevec

Showing 1 - 25 of 292
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia Trial in Beirut (Nilotinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Beirut, Lebanon
    American University of Beirut Medical Center
Feb 14, 2022

Gastrointestinal Stromal Tumor of Rectum Trial in Fuzhou (Imatinib Mesylate, Local resection)

Not yet recruiting
  • Gastrointestinal Stromal Tumor of Rectum
  • Imatinib Mesylate
  • Local resection
  • Fuzhou, Fujian, China
    Weizhong Jiang
Jul 23, 2023

Sarcoma Trial in Helsinki (Imatinib)

Recruiting
  • Sarcoma
  • Helsinki, Finland
    Helsinki University Central Hospital
Sep 26, 2022

Gastrointestinal Stromal Tumors Trial in Lexington (Imatinib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Lexington, Kentucky
    Markey Cancer Center
Aug 5, 2022

Imatinib With Hepatic Resection or Other Local Treatment for

Completed
  • GIST, Malignant
  • Liver Metastases
  • imatinib (IM)
  • +3 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Sep 12, 2023

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Eosinophilia, Hypereosinophilic Syndrome Trial in Stanford (Gleevec)

Terminated
  • Eosinophilia
  • Hypereosinophilic Syndrome
  • Gleevec
  • Stanford, California
    Stanford University School of Medicine
May 5, 2021

Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

Active, not recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 28, 2022

Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

Terminated
Has Results
  • Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 13, 2022

Liver Fibrosis Trial in Tehran (Imatinib 200mg, Placebo)

Active, not recruiting
  • Liver Fibrosis
  • Imatinib 200mg
  • Placebo
  • Tehran, Iran, Islamic Republic of
    Research Institute of Gastroenterology & Liver Diseases
Jan 24, 2022

Gastrointestinal Stromal Tumor, Malignant Trial in Changsha (Entacapone, Imatinib Mesylate)

Active, not recruiting
  • Gastrointestinal Stromal Tumor, Malignant
  • Changsha, Hunan, China
    Bin Li, MD
Nov 24, 2021

Uterine Cancer Trial in Houston (Imatinib Mesylate, Paclitaxel)

Terminated
Has Results
  • Uterine Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 26, 2020

TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy

Recruiting
  • Chronic Myeloid Leukemia
  • Pisa, Italy
  • +1 more
Jan 4, 2022

Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Imatinib Mesylate
  • Ipilimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • Detroit, Michigan
  • +1 more
May 3, 2022

Hematologic Malignancy Trial in United States (BBI608, Dexamethasone, Bortezomib)

Completed
  • Hematologic Malignancy
  • Denver, Colorado
  • +7 more
Apr 4, 2022

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

Gastrointestinal Stromal Tumors Trial in Worldwide (RAD001, Imatinib 600mg/day (Glevec is the brand name for imatinib), Imatinib

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Boston, Massachusetts
  • +15 more
Jun 3, 2021

Gastrointestinal Stromal Tumor Trial in Philadelphia (Conventional Surgery, Imatinib Mesylate)

Completed
Has Results
  • Gastrointestinal Stromal Tumor
  • Conventional Surgery
  • Imatinib Mesylate
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 22, 2020

Melanoma, Advanced Melanoma Trial in Philadelphia (Gleevec + Temozolomide)

Terminated
  • Melanoma
  • Advanced Melanoma
  • Gleevec + Temozolomide
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Apr 6, 2020

Systemic Sclerosis, Scleroderma Trial in Worldwide (STI571)

Completed
Has Results
  • Systemic Sclerosis, Scleroderma
  • Chicago, Illinois
  • +6 more
Jul 5, 2021

Plasmodium Falciparum Malaria Trial in Huong Hoa (Imatinib combination therapy, Dihydroartemisinin-piperaquine)

Completed
  • Plasmodium Falciparum Malaria
  • Huong Hoa, Quang Tri, Vietnam
    A Tuc
Feb 8, 2021

The Life After Stopping Tyrosine Kinase Inhibitors Study

Completed
  • Leukemia, Myeloid, Chronic
  • Imatinib (Stopping their TKI)
  • +3 more
  • San Francisco, California
  • +15 more
Jan 3, 2023

Philadelphia Chromosome Positive CML Trial in Worldwide (imatinib mesylate)

Completed
Has Results
  • Philadelphia Chromosome Positive CML
  • imatinib mesylate
  • Chicago, Illinois
  • +9 more
Jun 3, 2021

Colorectal Tumor, Colorectal Cancer Trial in Fairfax, Falls Church (Imatinib mesylate and panitumumab, Standard-of-care

Completed
Has Results
  • Colorectal Neoplasm
  • Colorectal Cancer
  • Imatinib mesylate and panitumumab
  • Standard-of-care treatment with panitumumab
  • Fairfax, Virginia
  • +1 more
Jun 12, 2020